QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TLRY

QT65Tilray Brands, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Canada
Latest market price
4.73
-0.02-0.42%
OverviewShort InterestFilings
TLRYQT65Tilray Brands, Inc.·NASDAQ
OverviewShort InterestFilings
4.73-0.42%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
-32.34
Insider Own22.62%
Shs Outstand120.82M
Perf Week-7.62%
Market Cap568.12MForward P/E78.83EPS next Y0.06Insider Trans-0.01%Shs Float-Perf Month-9.21%
Enterprise Value680.58MPEG0.00EPS next Q-0.01Inst Own-Short Float-Perf Quarter-28.98%
Income-1959499243.00P/S0.48EPS this Y98.97%Inst Trans-Short Ratio-Perf Half Y-66.07%
Sales1.18BP/B0.34EPS next Y118.05%ROA-88.98%Short Interest-Perf YTD-47.62%
Book/sh12.63P/C-EPS next 5Y-ROE-92.82%52W High23.20 -79.61%Perf Year23.18%
Cash/sh1.82P/FCF-EPS past 3/5Y-ROIC-100.85%52W Low3.51 34.76%Perf 3Y-
Dividend Est.-EV/EBITDA-0.37Sales past 3/5Y12.48% 30.74%Gross Margin27.67%Volatility3.04% 3.62%Perf 5Y-
Dividend TTM-EV/Sales0.58EPS Y/Y TTM89.02%Oper. Margin-172.33%ATR (14)0.28Perf 10Y-
Dividend Ex-Date-Quick Ratio1.66Sales Y/Y TTM6.14%Profit Margin-156.18%RSI (14)33.38Recom2.85
Dividend Gr. 3/5Y-Current Ratio2.79EPS Q/Q-310.00%SMA20-8.78%Beta2.02Target Price10.00
Payout0.00%Debt/Eq0.20Sales Q/Q5.22%SMA50-18.56%Rel Volume0.68Prev Close4.75
Employees2,650LT Debt/Eq0.20EarningsJul 27SMA200-48.22%Avg Volume5.20MPrice4.73
IPO DateJul 19, 2018Option/ShortYes / YesEPS/Sales Surpr.-192.86% 3.32%Net Debt/EBITDA-0.06Volume3,551,186Change-0.42%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-02-26UpgradeRoth CapitalNeutral → Buy
Jan-20-26ReiteratedRoth CapitalNeutral$4.00 → $10
Jan-09-26ReiteratedIndustrial Alliance Securities$20 → $10
Dec-19-25ReiteratedBernstein$1.00 → $10
Aug-25-25ReiteratedJefferiesBuy$1.50 → $2.00
Jul-29-25ReiteratedJefferiesBuy$2.50 → $1.50
Oct-11-24ReiteratedPiper SandlerNeutral$2.00
Sep-11-24ReiteratedJefferiesBuy$2.50
Jan-10-23ReiteratedIndustrial Alliance Securities$3.00
Sep-30-22ReiteratedBarclaysUnderweight$4.50 → $2.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
5/31/2025
FY 2024
5/31/2024
FY 2023
5/31/2023
FY 2022
5/31/2022
FY 2021
5/31/2021
FY 2020
5/31/2020
FY 2019
5/31/2019
FY 2018
5/31/2018
Total Revenue1,1411,1271,075
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A806797771
Gross Profit335330304
Selling, General and Administrative Excl. Other361356342
Research and Development001
Other Operating Expense3,1613,106199
Operating Income-3,187-3,132-238
Interest Expense415767
Unusual Expense
———
Non-Operating Income (Expense)-26-3034
Net Income Before Taxes-3,218-3,159-339
Income Taxes-166-166-36
Consolidated Net Income-3,059-3,001-334
Net Income From Continuing Operations-3,052-2,993-303
Net Income-3,059-3,001-334
EPS (Recurring)-32.34-33.80-4.50
EPS (Basic, Before Extraordinaries)-32.34-33.80-4.50
EPS (Diluted)-32.34-33.80-4.50
EBITDA-2,975-2,919-99
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.410.34—
Gross Margin29.3629.2828.28
Operating Margin-279.32-277.91-22.14
Net Margin-268.10-266.28-31.07
Shares Outstanding988974
Market Capitalization464379—
Operating Lease Expense
———
Insider Trading Volume
$5.20$4.83$4.47$4.11$3.74● Close Price0.00K58.22K116.44K174.66K232.88KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hopkinson David G.DirectorApr 21 '26Sale6.9433,556232,8790Apr 22 12:00 AM
Cohen Steven MichaelDirectorJan 07 '26Option Exercise4.5024,876111,81812,438Jan 08 12:00 AM
Merton Carl AChief Financial OfficerJul 31 '25Option Exercise0.39140,89254,478970,279Aug 04 12:00 AM
Gendel MitchellGlobal General CounselJul 31 '25Option Exercise0.39140,89254,478742,069Aug 04 12:00 AM
Gendel MitchellGlobal General CounselJul 31 '25Buy0.586,0003,496698,287Aug 04 12:00 AM
FALTISCHEK DENISE MChief Strategy OfficerJul 31 '25Option Exercise0.39140,89254,478874,564Aug 04 12:00 AM
SIMON IRWIN DPresident and CEOJul 31 '25Option Exercise0.391,059,324409,6055,200,788Aug 04 12:00 AM
Gendel MitchellGlobal General CounselJul 30 '25Option Exercise0.30487,562148,706777,345Jul 31 12:00 AM
FALTISCHEK DENISE MChief Strategy OfficerJul 30 '25Option Exercise0.30522,388159,328919,069Jul 31 12:00 AM
Clanachan David FDirectorJul 30 '25Option Exercise0.30248,75675,871236,880Jul 31 12:00 AM
Persofsky RenahDirectorJul 30 '25Option Exercise0.30248,75675,871199,726Jul 31 12:00 AM
Merton Carl AChief Financial OfficerJul 30 '25Option Exercise0.30333,116101,600964,627Jul 31 12:00 AM
SIMON IRWIN DPresident and CEOJul 30 '25Option Exercise0.302,352,934717,6455,118,100Jul 31 12:00 AM
Herhalt Johann MichaelDirectorJul 30 '25Option Exercise0.30248,75675,871239,930Jul 31 12:00 AM
Looney Thomas P.DirectorJul 30 '25Option Exercise0.30248,75675,871354,416Jul 31 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR